Urothelial Carcinoma Treatment in Malaysia
- Top Accredited Hospitals
- Global Medical Standards
- Cutting-Edge Technology
- Proven Treatment Options
- High Success Rate
- Trusted by Millions
What is Urothelial Carcinoma?
Carcinoma of the bladder, also known as transitional cell carcinoma, affects the urothelial cells that line the urinary tract—the bladder, the ureters, and a portion of the kidneys. Thus, it becomes the form most commonly associated with the bladder; however, it may also affect other urinary system structures.
What is the Importance of Timely Treatment?
Better Outcomes
One of the significant outcomes of early diagnosis and intervention of urothelial carcinoma is an increase in the chances of survival and the potential for recovery, especially in non-muscle-invasive cancers.
Prevention of metastasis
Timely intervention at this point can avoid the spread of cancer in another organ and subsequently reduce the need for less aggressive manipulation. Delayed treatments lead to greater chances of metastasis and increased risk of complications.
Complications Reduced
An early stage of treatment decreases the risk of developing more severe urinary and kidney problems, subsequently avoiding more complex surgical interventions. The saving grace is that timely treatment also reduces the probability of bladder dysfunction and cases of infection.
Better Treatment Options
The discovery of cancer in its early stages will often lead to less invasive treatments through either surgery/or immunotherapy, thus temporarily preserving bladder function.
What are the Common Symptoms of Urothelial Carcinoma?
- Hematuria (Blood in Urine)
- Painful Urination (Dysuria)
- Frequent Urination
- Urgency
- Lower Back Pain or Pelvic Pain
Causes and Risk Factors of Urothelial Carcinoma
Causes
Risk Factors
- Smoking
- Occupational Exposure
- Chronic Bladder Inflammation or Infection
- Age
- Gender
- Family History and Genetics
- Previous Cancer Treatments
- Diet and Hydration
- Chronic Catheter Use
Connect with our advisor for a PRIORITY response
Latest Research and Technologies in the Treatment of Urothelial Carcinoma in Malaysia
Malaysia progresses the treatment of urothelial carcinoma through innovative therapies and research. Few non-surgical options for treating low-grade upper tract urothelial carcinoma, with reasonable response rates. Targeted therapies such as erdafitinib are not yet locally approved but hold promise for patients with FGFR genetic alterations. Immunotherapies elicit impressive response rates, with nivolumab and enfortumab vedotin possibly improving survival rates. In addition, Malaysian researchers are developing 3D culture models to study the disease better. Together, all these efforts indicate that Malaysia is becoming increasingly active in pioneering work involving the care of urothelial carcinoma.
Urothelial Carcinoma Prevention Tip:
Stop smoking
The highest risk factor for urothelial carcinoma is smoking, and quitting smoking dramatically reduces the risk of bladder cancer.
Hydration
Adequate liquid intake must include a lot of water, as this flushes potential carcinogens out of the bladder, diminishing cancer risk.
Limit Exposure to Nitrogen Compounds
Personal protective equipment is advised while working in industries where chemicals like aromatic amines (used in dyes, rubber, etc.) are present.
Eat Healthy
Balanced nutrition, with plenty of fruits, vegetables, and fibre but low fats, may help reduce bladder cancer risks.
Regular Screening
Regular screenings with urine tests and cystoscopy can pick up early signs of urothelial carcinoma and, hence, timely treatment in high-risk categories (e.g., smokers or those with a family history).
Treatment options for Urothelial Carcinoma
Transurethral Resection of Bladder Tumour (TURBT): minimally invasive surgery for surgically removing superficial tumours from the bladder.
Chemotherapy : It is intravesical for superficial tumours, while systemic (e.g., Gemcitabine and cisplatin) for tumours that have grown into muscle or metastasised.
Cost Start From USD 1500 - USD 3500Explore Options
Immunotherapy : Checkpoint inhibitors stimulate the immune system to attack cancer cells and are used mainly in advanced or resistant cases of chemotherapy.
Cost Start From USD 15000 - USD 50000Explore Options
Radiation Therapy: Advanced palliative care based on external beam radiation can involve using this radiation either alone or following surgery. The advanced disease can also be treated because symptoms such as bleeding and obstruction require palliative care.
Targeted Therapy and BCG: Targeted medications that aim at specific genetic mutations. However, BCG activates the immune system against non-muscle-invasive bladder cancer, improving outcomes.
Cost Start From USD 2000 - USD 10000Explore Options
These are the standard diagnostic methods for diagnosing Urothelial Carcinoma:
Imaging Studies
- Cystoscopy: A cystoscope allows the introduction of a thin tube with a camera into the bladder through the urethra. It directly helps view the bladder's lining, detects tumours and performs biopsies.
- CT Urography: CT Urography is the procedure by which pictures of the urinary system are generated from different angles using a CT scan to visualise tumours in the bladder, kidneys, and ureters.
- MRI: MRI is used in a few select cases to check for muscular wall invasion and assess the bladder wall and adjacent tissues.
- Ultrasound is an imaging technique for evaluating the kidneys and bladder and checking for abnormalities; it is less precise than CT and MRI.
Biopsy
- Tissue sampling is conducted at the suspected sites, usually during cystoscopy, to confirm cancer detection. A biopsy assists in determining the tumour's grade and stage and contributes to further management.
Urine and Blood Tests
- Urine Cytology: A test that puts urine under a microscope to look for cancer cells. It will detect high-grade urothelial carcinomas, but low-grade ones may escape detection.
MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive rehabilitation services to support patients through Teleconsulations and online therapy sessions.
- Physical Rehabilitation: Post-surgery rehab mainly helps patients regain strength and mobility after surgeries such as cystectomy. Strengthening exercises concentrate on the core and pelvic floor functionalities to raise fitness standards.
- Pelvic Floor Therapy: Pelvic floor rehabilitation works with bladder control and incontinence after surgery, which patients experience through exercises targeting pelvic muscles for improved functioning.
- Psychosocial Support: Mental health counselling and support groups provide an essential mental well-being and emotional adjustment in recovery from emotional challenges that come from the treatment of cancer.
- Lifestyle Modifications: The dietitian assists the patient in having a balanced diet while in recovery so that the patient attains maximum nutrition and hydration in the healing process. Diet advice also focuses on weight management and general well-being.
- Management of lymphedema: Swelling can occur after removing lymph nodes, which is treated with compression therapy, massage, and exercises to keep swelling down and help movement.
Instantly Connect with our Specialists
Hospitals for Urothelial Carcinoma in Malaysia
Sunway Medical Centre
Kuala Lumpur, Malaysia
Sunway Medical Centre has initiated a comprehensive expansion plan close to its current hospital facility to enhance its ability to provide services to the global market. The new Cancer Radiosurgery Center and Nuclear Medicine Center, which will also house additional Centers of Excellence like the Digestive Health Center and Dialysis Center, marked the completion of Tower C's first phase in October 2016.
Ara Damansara Medical Centre
Kuala Lumpur, Malaysia
Situated at the junction of Petaling Jaya and Shah Alam, close to the Oasis Ara, Ara Damansara Medical Centre boasts a serene, luxurious ambiance.
The Centre has been awarded several prestigious awards such as the Global Health Asia Pacific Awards 2023, Newsweek Best Specialized Hospital APAC 2023, Healthcare Asia Awards 2023, and Malaysian Healthcare Wellness Excellence.
Prince Court Medical Centre
Kuala Lumpur, Malaysia
Prince Court is a private medical facility in the center of Kuala Lumpur that has 277 individual beds. Our dedication is to provide you with the best treatment possible from the time you arrive until you depart, healthier and happier. We are well-known for our top-notch facilities, cutting-edge technology, and friendly customer service.
Our Services to better your experience
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Why Choose Malaysia for Urothelial Carcinoma Treatment?
The following are the growing reasons for Malaysia being frequented for Urothelial Carcinoma treatment:
- Advanced Medical Facilities in Malaysia: All Malaysian clinics have state-of-the-art, accurate diagnosis and treatment equipment.
- Experienced Specialists: Most Malaysian doctors are further trained abroad and have immense experience treating chronic painful conditions.
- Affordable Treatments: In Malaysia, high-quality medical services are available at much lower rates than in several other countries.
- Comprehensive Treatment Options: Malaysia has all the treatment modalities, from minimally invasive procedures to holistic therapies.
- Cultural and Touristic Interest: Individuals can enjoy their treatment by visiting Malaysia's rich culture and landscapes.
Frequently Asked Questions
Although one cannot prevent the disease, risk factor reduction- for example, quitting smoking, eating good food, staying hydrated, and avoiding chemicals can reduce the possibility of urothelial carcinoma development.
The prognosis is determined by the stage at which the cancer was diagnosed. Late-stage tumours are considered aggressive and associated with a poor prognosis, while early-stage non-muscle-invasive bladder cancer is associated with a reasonable survival rate.
PCPS and immune checkpoint inhibitors support a patient's immune system in recognising and destroying cancer cells in advanced or metastatic urothelial carcinoma cases.
Yes, urothelial carcinoma can recur, particularly in the setting of non-muscle invasive cancers. Follow-up through cystoscopies and urine tests can help detect recurrences as early as possible.
The side effects may change from treatment to treatment. They include fatigue, nausea, hair loss, urinary problems, infections, and immune-mediated side effects (in the case of immunotherapy). Managing side effects is the most critical part of the treatment journey.
It has been incorporated into many hospitals for good precision and quick recovery.
Most hospitals have international patient departments that deal with travel, appointments, and treatment programs.
Malaysia has become well-known for second medical opinions: expert specialists, state-of-the-art diagnostic resources, and most of all, low cost. Efficient international patient services have very short waiting times. Medigence provides this service worldwide. To know more, visit our website.